2nd Quarter - Report

INVARIANT LLC for CIGNA CORPORATION

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, and H.R. 1628, the American Health Care Act of 2017, the Better Care Reconciliation Act, including exchanges, cost sharing reduction, market reforms, and non-discrimination provisions. The high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and H.R. 4616, regarding a one-year delay of the Cadillac Tax. H.R. 4620, regarding relief from the Health Insurance Tax. Substance use disorders and 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records, specifically H.R. 3545, H.R. 5795, and H.R.6082, the Overdose Prevention and Patient Safety Act (OPPS Act). Issues related to proposed changes to the definition of Employer Under Section 3(5) of ERISA for Association Health Plans.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
ANNE PALISI —
HEATHER PODESTA —
KATHRYN WISE New Leg. Dir, Rep. Vern Buchanan (2014-2015) Leg. Dir, Rep. Mike Fitzpatrick (2013-2014) Sr. Legislative Asst, Rep. Mike Fitzpatrick (2011-2013) Legislative Correspondent/Asst, Rep. Mary Fallin (2010-2011) Staff Asst, Rep. Mary Fallin (2009-2010)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4620 (115th), H.R. 3545 (115th), H.R. 173 (115th), H.R. 5795 (115th), H.R. 6082 (115th), H.R. 1628 (115th), S. 58 (115th), H.R. 4616 (115th)

Taxation/Internal Revenue Code TAX

Issues related to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act. The high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and H.R.5963, regarding relief from the Health Insurance Tax. Issues related to the implementation of international tax provisions under P.L. 115-97, the Tax Cuts and Jobs Act.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
ANNE PALISI —
HEATHER PODESTA —
KATHRYN WISE New Leg. Dir, Rep. Vern Buchanan (2014-2015) Leg. Dir, Rep. Mike Fitzpatrick (2013-2014) Sr. Legislative Asst, Rep. Mike Fitzpatrick (2011-2013) Legislative Correspondent/Asst, Rep. Mary Fallin (2010-2011) Staff Asst, Rep. Mary Fallin (2009-2010)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 58 (115th), H.R. 173 (115th), H.R. 5963 (115th)

Labor Issues/Antitrust/Workplace LBR

Issues related to antitrust and the proposed Cigna-Express Scripts transaction. Issues related to proposed changes to the definition of Employer Under Section 3(5) of ERISA for Association Health Plans.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
ANNE PALISI —
HEATHER PODESTA —
KATHRYN WISE New Leg. Dir, Rep. Vern Buchanan (2014-2015) Leg. Dir, Rep. Mike Fitzpatrick (2013-2014) Sr. Legislative Asst, Rep. Mike Fitzpatrick (2011-2013) Legislative Correspondent/Asst, Rep. Mary Fallin (2010-2011) Staff Asst, Rep. Mary Fallin (2009-2010)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. CMS-4182-P/CMS-4182-CN: Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2019. Issues related to the opioid epidemic and introduced H.R. 6, SUPPORT for Patients and Communities Act.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
ANNE PALISI —
HEATHER PODESTA —
KATHRYN WISE New Leg. Dir, Rep. Vern Buchanan (2014-2015) Leg. Dir, Rep. Mike Fitzpatrick (2013-2014) Sr. Legislative Asst, Rep. Mike Fitzpatrick (2011-2013) Legislative Correspondent/Asst, Rep. Mary Fallin (2010-2011) Staff Asst, Rep. Mary Fallin (2009-2010)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.